• LAST PRICE
    0.5399
  • TODAY'S CHANGE (%)
    Trending Down-0.0091 (-1.6576%)
  • Bid / Lots
    0.5356/ 3
  • Ask / Lots
    0.5400/ 70
  • Open / Previous Close
    0.5500 / 0.5490
  • Day Range
    Low 0.5100
    High 0.5599
  • 52 Week Range
    Low 0.2700
    High 1.1000
  • Volume
    136,700
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.549
TimeVolumeDARE
09:32 ET487940.54
09:34 ET119000.5402
09:36 ET2000.55
09:38 ET58470.54
09:39 ET10600.5102
09:41 ET1000.511928
09:45 ET13920.5251
09:48 ET5000.5326
09:50 ET5500.54
09:52 ET51280.51
09:54 ET7210.54
09:57 ET74000.55
09:59 ET39660.5101
10:03 ET12000.5399
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDARE
Dare Bioscience Inc
54.1M
-1.1x
---
United StatesCRIS
Curis Inc
64.1M
-1.2x
---
United StatesIKNA
Ikena Oncology Inc
67.1M
-0.9x
---
United StatesBOLT
Bolt Biotherapeutics Inc
46.5M
-0.7x
---
United StatesDRRX
DURECT Corp
40.0M
-1.1x
---
United StatesSPRB
Spruce Biosciences Inc
30.5M
-0.6x
---
As of 2024-03-28

Company Information

Dare Bioscience, Inc. is a biopharmaceutical company. The Company is engaged in identifying, developing, and marketing a portfolio of differentiated therapies that prioritize women's health and well-being, primarily in the areas of contraception, vaginal health, reproductive health, menopause, sexual health and fertility. Its first product, XACIATO, is a clindamycin phosphate vaginal gel used for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its pipeline includes various other clinical-stage programs, such as Ovaprene, Sildenafil Cream 3.6%, DARE-HRT1, DARE-VVA1, DARE-FRT1 and DARE-PTB1. Its pre-clinical-stage programs include DARE-LARC1, DARE-GML, DARE-LBT, and DARE-RH1. Ovaprene is an investigational hormone-free monthly intravaginal contraceptive. Sildenafil Cream 3.6% is a proprietary cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder (FSAD).

Contact Information

Headquarters
3655 Nobel Dr Ste 260SAN DIEGO, CA, United States 92122-1050
Phone
858-926-7655
Fax
302-636-5454

Executives

Independent Chairman of the Board
William Rastetter
President, Chief Executive Officer, Principal Financial Officer, Company Secretary, Director
Sabrina Johnson
Chief Commercial Officer
John Fair
Independent Director
Cheryl Blanchard
Independent Director
Jessica Grossman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$54.1M
Revenue (TTM)
$1.0M
Shares Outstanding
98.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.17
EPS
$-0.48
Book Value
$0.13
P/E Ratio
-1.1x
Price/Sales (TTM)
54.1
Price/Cash Flow (TTM)
---
Operating Margin
-4,199.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.